<?xml version="1.0" encoding="UTF-8"?>
<billStatus>
  <bill>
    <laws />
    <amendments />
    <introducedDate>2016-06-14</introducedDate>
    <subjects>
      <billSubjects>
        <legislativeSubjects>
          <item>
            <name>Civil actions and liability</name>
          </item>
          <item>
            <name>Drug safety, medical device, and laboratory regulation</name>
          </item>
          <item>
            <name>Licensing and registrations</name>
          </item>
          <item>
            <name>Prescription drugs</name>
          </item>
          <item>
            <name>Product development and innovation</name>
          </item>
        </legislativeSubjects>
        <policyArea>
          <name>Health</name>
        </policyArea>
      </billSubjects>
    </subjects>
    <billNumber>3056</billNumber>
    <title>CREATES Act of 2016</title>
    <congress>114</congress>
    <sponsors>
      <item>
        <byRequestType />
        <party>D</party>
        <bioguideId>L000174</bioguideId>
        <firstName>PATRICK</firstName>
        <lastName>LEAHY</lastName>
        <middleName>JOSEPH</middleName>
        <fullName>Sen. Leahy, Patrick J. [D-VT]</fullName>
        <identifiers>
          <gpoId>8244</gpoId>
          <lisID>1383</lisID>
          <bioguideId>L000174</bioguideId>
        </identifiers>
        <state>VT</state>
      </item>
    </sponsors>
    <updateDate>2018-06-02T07:46:25Z</updateDate>
    <recordedVotes />
    <notes />
    <actions>
      <actionByCounts>
        <senate>3</senate>
      </actionByCounts>
      <item>
        <actionDate>2016-06-21</actionDate>
        <committee>
          <systemCode>ssju01</systemCode>
          <name>Antitrust, Competition Policy and Consumer Rights Subcommittee</name>
        </committee>
        <links />
        <sourceSystem>
          <name>Senate</name>
          <code>0</code>
        </sourceSystem>
        <text>Committee on the Judiciary Subcommittee on Antitrust, Competition Policy and Consumer Rights. Hearings held.</text>
        <type>Committee</type>
      </item>
      <item>
        <actionDate>2016-06-14</actionDate>
        <committee>
          <systemCode>ssju00</systemCode>
          <name>Judiciary Committee</name>
        </committee>
        <links>
          <link>
            <name>S3862-3863</name>
            <url>https://www.congress.gov/congressional-record/volume-162/senate-section/page/S3862-3863</url>
          </link>
        </links>
        <sourceSystem>
          <name>Senate</name>
          <code>0</code>
        </sourceSystem>
        <text>Read twice and referred to the Committee on the Judiciary. (Sponsor introductory remarks on measure: CR S3862-3863)</text>
        <type>IntroReferral</type>
      </item>
      <item>
        <links />
        <actionDate>2016-06-14</actionDate>
        <committee />
        <type>IntroReferral</type>
        <sourceSystem>
          <name>Library of Congress</name>
          <code>9</code>
        </sourceSystem>
        <actionCode>10000</actionCode>
        <text>Introduced in Senate</text>
      </item>
      <actionTypeCounts>
        <hearingsHeld>1</hearingsHeld>
        <referredToCommittee>1</referredToCommittee>
        <introducedInSenate>1</introducedInSenate>
      </actionTypeCounts>
    </actions>
    <calendarNumbers />
    <originChamber>Senate</originChamber>
    <cboCostEstimates />
    <relatedBills />
    <policyArea>
      <name>Health</name>
    </policyArea>
    <summaries>
      <billSummaries>
        <item>
          <text><![CDATA[<p><b>Creating and Restoring Equal Access to Equivalent Samples Act of 2016 or the CREATES Act of 2016</b></p> <p>This bill permits the developer of a drug or biological product to bring a civil action against the license holder of an approved medication alleging that the license holder: (1) declined to make available sufficient quantities of the approved medication for the developer's testing; or (2) failed to agree on, or refused to allow the developer to join, a single, shared system of elements to assure safe use (ETASU) of the medication. (Under current law, a generic version of a medication with ETASU must join the brand name medication's system of ETASU unless the developer of the generic has a waiver from the Food and Drug Administration.) The bill does not apply to medications for which there is a shortage, unless the shortage will not be promptly resolved.</p> <p>In a civil action regarding the availability of sufficient quantities of a medication, it is an affirmative defense that the license holder: (1) is not manufacturing or marketing the medication and does not have access to a supply of the medication to make available, or (2) sells the medication without restrictions through other entities and the developer can purchase sufficient quantities of the medication from those entities. </p>]]></text>
          <actionDesc>Introduced in Senate</actionDesc>
          <updateDate>2016-06-14T04:00:00Z</updateDate>
          <versionCode>00</versionCode>
          <name>Introduced in Senate</name>
          <actionDate>2016-06-14</actionDate>
          <lastSummaryUpdateDate>2017-04-19T19:49:44Z</lastSummaryUpdateDate>
        </item>
      </billSummaries>
    </summaries>
    <titles>
      <item>
        <chamberCode />
        <chamberName />
        <titleType>Short Titles as Introduced</titleType>
        <title>CREATES Act of 2016</title>
        <parentTitleType />
      </item>
      <item>
        <chamberCode />
        <chamberName />
        <titleType>Short Titles as Introduced</titleType>
        <title>Creating and Restoring Equal Access to Equivalent Samples Act of 2016</title>
        <parentTitleType />
      </item>
      <item>
        <chamberCode />
        <chamberName />
        <titleType>Official Title as Introduced</titleType>
        <title>A bill to provide for certain causes of action relating to delays of generic drugs and biosimilar biological products.</title>
        <parentTitleType />
      </item>
      <item>
        <chamberCode />
        <chamberName />
        <titleType>Display Title</titleType>
        <title>CREATES Act of 2016</title>
        <parentTitleType />
      </item>
    </titles>
    <createDate>2016-06-15T05:49:25Z</createDate>
    <committees>
      <billCommittees>
        <item>
          <systemCode>ssju00</systemCode>
          <activities>
            <item>
              <date>2016-06-14T20:53:09Z</date>
              <name>Referred to</name>
            </item>
          </activities>
          <chamber>Senate</chamber>
          <subcommittees>
            <item>
              <systemCode>ssju01</systemCode>
              <activities>
                <item>
                  <date>2016-06-21T18:08:34Z</date>
                  <name>Hearings by</name>
                </item>
              </activities>
              <name>Antitrust, Competition Policy and Consumer Rights Subcommittee</name>
            </item>
          </subcommittees>
          <type>Standing</type>
          <name>Judiciary Committee</name>
        </item>
      </billCommittees>
    </committees>
    <cosponsors>
      <item>
        <firstName>CHARLES</firstName>
        <isOriginalCosponsor>True</isOriginalCosponsor>
        <fullName>Sen. Grassley, Chuck [R-IA]</fullName>
        <sponsorshipDate>2016-06-14</sponsorshipDate>
        <identifiers>
          <lisID>457</lisID>
          <bioguideId>G000386</bioguideId>
          <gpoId>8316</gpoId>
        </identifiers>
        <bioguideId>G000386</bioguideId>
        <party>R</party>
        <state>IA</state>
        <sponsorshipWithdrawnDate />
        <lastName>GRASSLEY</lastName>
        <middleName>ERNEST</middleName>
      </item>
      <item>
        <firstName>Amy</firstName>
        <isOriginalCosponsor>True</isOriginalCosponsor>
        <fullName>Sen. Klobuchar, Amy [D-MN]</fullName>
        <sponsorshipDate>2016-06-14</sponsorshipDate>
        <identifiers>
          <gpoId>8249</gpoId>
          <bioguideId>K000367</bioguideId>
          <lisID>1826</lisID>
        </identifiers>
        <bioguideId>K000367</bioguideId>
        <party>D</party>
        <state>MN</state>
        <sponsorshipWithdrawnDate />
        <lastName>Klobuchar</lastName>
        <middleName />
      </item>
      <item>
        <firstName>Mike</firstName>
        <isOriginalCosponsor>True</isOriginalCosponsor>
        <fullName>Sen. Lee, Mike [R-UT]</fullName>
        <sponsorshipDate>2016-06-14</sponsorshipDate>
        <identifiers>
          <bioguideId>L000577</bioguideId>
          <gpoId>8303</gpoId>
          <lisID>2080</lisID>
        </identifiers>
        <bioguideId>L000577</bioguideId>
        <party>R</party>
        <state>UT</state>
        <sponsorshipWithdrawnDate />
        <lastName>Lee</lastName>
        <middleName />
      </item>
      <item>
        <firstName>SUSAN</firstName>
        <isOriginalCosponsor>False</isOriginalCosponsor>
        <fullName>Sen. Collins, Susan M. [R-ME]</fullName>
        <sponsorshipDate>2016-06-21</sponsorshipDate>
        <identifiers>
          <gpoId>8291</gpoId>
          <lisID>1541</lisID>
          <bioguideId>C001035</bioguideId>
        </identifiers>
        <bioguideId>C001035</bioguideId>
        <party>R</party>
        <state>ME</state>
        <sponsorshipWithdrawnDate />
        <lastName>COLLINS</lastName>
        <middleName>MARGARET</middleName>
      </item>
      <item>
        <firstName>Claire</firstName>
        <isOriginalCosponsor>False</isOriginalCosponsor>
        <fullName>Sen. McCaskill, Claire [D-MO]</fullName>
        <sponsorshipDate>2016-06-21</sponsorshipDate>
        <identifiers>
          <lisID>1820</lisID>
          <bioguideId>M001170</bioguideId>
          <gpoId>8252</gpoId>
        </identifiers>
        <bioguideId>M001170</bioguideId>
        <party>D</party>
        <state>MO</state>
        <sponsorshipWithdrawnDate />
        <lastName>McCaskill</lastName>
        <middleName />
      </item>
      <item>
        <firstName>Richard</firstName>
        <isOriginalCosponsor>False</isOriginalCosponsor>
        <fullName>Sen. Blumenthal, Richard [D-CT]</fullName>
        <sponsorshipDate>2016-07-14</sponsorshipDate>
        <identifiers>
          <lisID>2076</lisID>
          <gpoId>8332</gpoId>
          <bioguideId>B001277</bioguideId>
        </identifiers>
        <bioguideId>B001277</bioguideId>
        <party>D</party>
        <state>CT</state>
        <sponsorshipWithdrawnDate />
        <lastName>Blumenthal</lastName>
        <middleName />
      </item>
      <item>
        <firstName>JOHN</firstName>
        <isOriginalCosponsor>False</isOriginalCosponsor>
        <fullName>Sen. McCain, John [R-AZ]</fullName>
        <sponsorshipDate>2016-07-14</sponsorshipDate>
        <identifiers>
          <lisID>754</lisID>
          <bioguideId>M000303</bioguideId>
          <gpoId>8253</gpoId>
        </identifiers>
        <bioguideId>M000303</bioguideId>
        <party>R</party>
        <state>AZ</state>
        <sponsorshipWithdrawnDate />
        <lastName>MCCAIN</lastName>
        <middleName>SIDNEY</middleName>
      </item>
      <item>
        <firstName>Sheldon</firstName>
        <isOriginalCosponsor>False</isOriginalCosponsor>
        <fullName>Sen. Whitehouse, Sheldon [D-RI]</fullName>
        <sponsorshipDate>2016-09-13</sponsorshipDate>
        <identifiers>
          <bioguideId>W000802</bioguideId>
          <gpoId>8264</gpoId>
          <lisID>1823</lisID>
        </identifiers>
        <bioguideId>W000802</bioguideId>
        <party>D</party>
        <state>RI</state>
        <sponsorshipWithdrawnDate />
        <lastName>Whitehouse</lastName>
        <middleName />
      </item>
      <item>
        <firstName>David</firstName>
        <isOriginalCosponsor>False</isOriginalCosponsor>
        <fullName>Sen. Vitter, David [R-LA]</fullName>
        <sponsorshipDate>2016-09-13</sponsorshipDate>
        <identifiers>
          <lisID>1609</lisID>
          <gpoId>8267</gpoId>
          <bioguideId>V000127</bioguideId>
        </identifiers>
        <bioguideId>V000127</bioguideId>
        <party>R</party>
        <state>LA</state>
        <sponsorshipWithdrawnDate />
        <lastName>Vitter</lastName>
        <middleName />
      </item>
      <item>
        <firstName>RICHARD</firstName>
        <isOriginalCosponsor>False</isOriginalCosponsor>
        <fullName>Sen. Durbin, Richard J. [D-IL]</fullName>
        <sponsorshipDate>2016-09-22</sponsorshipDate>
        <identifiers>
          <lisID>326</lisID>
          <bioguideId>D000563</bioguideId>
          <gpoId>8326</gpoId>
        </identifiers>
        <bioguideId>D000563</bioguideId>
        <party>D</party>
        <state>IL</state>
        <sponsorshipWithdrawnDate />
        <lastName>DURBIN</lastName>
        <middleName>J.</middleName>
      </item>
      <item>
        <firstName>Tom</firstName>
        <isOriginalCosponsor>False</isOriginalCosponsor>
        <fullName>Sen. Cotton, Tom [R-AR]</fullName>
        <sponsorshipDate>2016-09-22</sponsorshipDate>
        <identifiers>
          <gpoId />
          <lisID>2098</lisID>
          <bioguideId>C001095</bioguideId>
        </identifiers>
        <bioguideId>C001095</bioguideId>
        <party>R</party>
        <state>AR</state>
        <sponsorshipWithdrawnDate />
        <lastName>Cotton</lastName>
        <middleName />
      </item>
    </cosponsors>
    <version>1.0.0</version>
    <latestAction>
      <links />
      <actionDate>2016-06-21</actionDate>
      <text>Committee on the Judiciary Subcommittee on Antitrust, Competition Policy and Consumer Rights. Hearings held.</text>
    </latestAction>
    <billType>S</billType>
    <committeeReports />
  </bill>
  <dublinCore xmlns:dc="http://purl.org/dc/elements/1.1/">
    <dc:format>text/xml</dc:format>
    <dc:language>EN</dc:language>
    <dc:rights>Pursuant to Title 17 Section 105 of the United States Code, this file is not subject to copyright protection and is in the public domain.</dc:rights>
    <dc:contributor>Congressional Research Service, Library of Congress</dc:contributor>
    <dc:description>This file contains bill summaries and statuses for federal legislation. A bill summary describes the most significant provisions of a piece of legislation and details the effects the legislative text may have on current law and federal programs. Bill summaries are authored by the Congressional Research Service (CRS) of the Library of Congress. As stated in Public Law 91-510 (2 USC 166 (d)(6)), one of the duties of CRS is "to prepare summaries and digests of bills and resolutions of a public general nature introduced in the Senate or House of Representatives". For more information, refer to the User Guide that accompanies this file.</dc:description>
  </dublinCore>
</billStatus>

